For example, in the FY 2021 IPPS final rule we stated that we believe the rates that hospitals negotiate with MAOs capture the relative resource use to provide services to patients in order to maximize profits (or, in the case of not-for-profit hospitals, net income), subject to market constraints and conditions (supply and demand, community benefit requirements, etc.)
Kikuchi E, Margulis V, Karakiewicz PI, Roscigno M, Mikami S, Lotan Y, et al
What I like most is that it feels designed for normal real-world use rather than forcing people into a research-chemical workflow they may not actually want
It reflects a broader shift in how HHS under Secretary Kennedy is approaching the intersection of patient access, clinical innovation, and regulatory oversight
The studies on learning showed that neuroenhancers did improve retention
comes with a price but promos are ran often